Predictive Factors in Response to Inhaled Corticoids in Chronic Cough

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02715167

Acronym

FeNOTX

Enrollment

100

Registered

2016-03-22

Start date

2016-03-31

Completion date

2017-12-31

Last updated

2016-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The hypothesis is that a high fractional exhaled nitric oxide can predict the response to inhaled corticoids in chronic cough.

Interventions

DRUGBudesonide novolizer

DRUGPlacebo

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* chronic cough

Exclusion criteria

* active smoker * treated by corticoids during the previous month * use of angiotensin-converting-enzyme inhibitor

Design outcomes

Primary

Measure	Time frame
Leicester cough questionnaire	5 minutes

Contacts

Primary ContactRougui Ihsan, MD

ihsan.rougui@hotmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026